2005
DOI: 10.1128/jvi.79.21.13239-13249.2005
|View full text |Cite
|
Sign up to set email alerts
|

Selective Escape from CD8 + T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution

Abstract: The sequence diversity of human immunodeficiency virus type 1 (HIV-1) represents a major obstacle to the development of an effective vaccine, yet the forces impacting the evolution of this pathogen remain unclear. To address this issue we assessed the relationship between genome-wide viral evolution and adaptive CD8؉ T-cell responses in four clade B virus-infected patients studied longitudinally for as long as 5 years after acute infection. Of the 98 amino acid mutations identified in nonenvelope antigens, 53%… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

18
307
1

Year Published

2007
2007
2013
2013

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 303 publications
(326 citation statements)
references
References 60 publications
18
307
1
Order By: Relevance
“…It could be argued that HIV has already escaped to the immune system of the patient so boosting with the same virus will not improve the breadth of the immune response and would not be effective. However, although it is true that viral escape to CTL has been extensively demonstrated, [30][31][32][33] some data suggest that the antigen-presenting functions of dendritic cells are impaired in HIV-1 infected patients and this could contribute to the functional defects of HIV-1-specific helper and CTL responses. 34,35 We think that our model could help to know if a correct antigen presentation with this therapeutic vaccine could reverse the functional defect of helper and CTL responses and prevent, at least partially, the viral escape.…”
Section: Myeloid-derived Dendritic Cells (Md-dc) As a Cellular Adjuvamentioning
confidence: 99%
“…It could be argued that HIV has already escaped to the immune system of the patient so boosting with the same virus will not improve the breadth of the immune response and would not be effective. However, although it is true that viral escape to CTL has been extensively demonstrated, [30][31][32][33] some data suggest that the antigen-presenting functions of dendritic cells are impaired in HIV-1 infected patients and this could contribute to the functional defects of HIV-1-specific helper and CTL responses. 34,35 We think that our model could help to know if a correct antigen presentation with this therapeutic vaccine could reverse the functional defect of helper and CTL responses and prevent, at least partially, the viral escape.…”
Section: Myeloid-derived Dendritic Cells (Md-dc) As a Cellular Adjuvamentioning
confidence: 99%
“…T he ability of viruses to establish chronic infections requires one or more mechanisms to escape the destruction of infected cells by CD8 + cytotoxic T lymphocytes (CTLs) (1,2). One such mechanism appears to be the induction of regulatory T cells (Tregs), a specialized subset of CD4-expressing T cells that can suppress the proliferation and/or function of effector T cells (3).…”
Section: Cytotoxic T Cells | Retrovirus | Friend Virusmentioning
confidence: 99%
“…Though many groups have examined proviral SIV (23) and HIV (1,20) sequences from individuals who control virus, the relationship between these sequences and replicating virus is questionable (2). We coupled ultrasensitive viral RNA extraction with reverse transcription-PCR using amplification primers flanking the Nef IW9 epitope sequence to extract viral sequence from plasma virus.…”
Section: An Unresolved Question Is Whether Differences In Mamu-b*17-rmentioning
confidence: 99%